Telemedicine-enabled Diagnostic Software Platform

Intelligent Retinal Imaging Systems is the industry leader in early detection systems for diabetic eye disease. The company's IRIS solution is an end-to-end FDA-cleared, telemedicine system that has improved quality, expanded access and reduced costs for diabetic retinopathy exams across the U.S. IRIS was founded in 2011 by nationally recognized retina surgeon Dr. Sunil Gupta, with a vision to end preventable blindness through the development and deployment of retinal diagnostic services in the primary care setting. The IRIS team of physicians, technicians and best practice client success experts partner with forward-thinking providers and payers to enhance patient outcomes by closing care gaps in healthcare systems. IRIS is the recipient of the 2017 Microsoft Innovation Award and the 2016 Frost & Sullivan New Product Innovation Award in Diabetic Retinopathy.

Syndicate Partners: Ballast Point Ventures, CoxHealth

 Visit website >

Check out this episode of Funding The Future of Healthcare, where we were joined by IRIS’s Founder, Dr. Sunil Gupta: